MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

Akira Tomokuni, Hidetoshi Eguchi, Yoshito Tomimaru, Hiroshi Wada, Koichi Kawamoto, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Hiroaki Nagano, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Interferon-based (IFN-based) therapy is effective in the treatment of advanced hepatocellular carcinoma (HCC). However, the issue of resistance to this therapy remains to be solved. The aim of this study was to identify microRNAs (miRNAs) that govern the sensitivity to IFN-α in HCC cells. Methods: miRNA microarray analysis using IFN-α-resistant clones of PLC/PRF/5 (PLC-Rs) and their parental cells (PLC-P) was conducted. Changes in the anti-cancer effects of IFN-α were studied after gain-of-function and loss-of-function of the candidate miRNA. Results: miR-146a expression was significantly higher in PLC-Rs than in PLC-P. miR-146a decreased the sensitivity to IFN-α through the suppression of apoptosis. Further experiments showed that miR-146a-related resistance to IFN-α was mediated through SMAD4. Conclusions: The results indicated that miR-146a regulated the sensitivity of HCC cells to the cytotoxic effects of IFN-α through SMAD4, suggesting that this miRNA could be suitable for prediction of the clinical response and potential therapeutic target in HCC patients on IFN-based therapy.

Original languageEnglish
Pages (from-to)675-680
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume414
Issue number4
DOIs
Publication statusPublished - Nov 4 2011

Fingerprint

Programmable logic controllers
Interferons
Hepatocellular Carcinoma
MicroRNAs
Cells
Therapeutics
Microarray Analysis
Microarrays
Clone Cells
Apoptosis
Neoplasms
Experiments

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Tomokuni, A., Eguchi, H., Tomimaru, Y., Wada, H., Kawamoto, K., Kobayashi, S., ... Doki, Y. (2011). MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications, 414(4), 675-680. https://doi.org/10.1016/j.bbrc.2011.09.124

MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells. / Tomokuni, Akira; Eguchi, Hidetoshi; Tomimaru, Yoshito; Wada, Hiroshi; Kawamoto, Koichi; Kobayashi, Shogo; Marubashi, Shigeru; Tanemura, Masahiro; Nagano, Hiroaki; Mori, Masaki; Doki, Yuichiro.

In: Biochemical and Biophysical Research Communications, Vol. 414, No. 4, 04.11.2011, p. 675-680.

Research output: Contribution to journalArticle

Tomokuni, A, Eguchi, H, Tomimaru, Y, Wada, H, Kawamoto, K, Kobayashi, S, Marubashi, S, Tanemura, M, Nagano, H, Mori, M & Doki, Y 2011, 'MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells', Biochemical and Biophysical Research Communications, vol. 414, no. 4, pp. 675-680. https://doi.org/10.1016/j.bbrc.2011.09.124
Tomokuni, Akira ; Eguchi, Hidetoshi ; Tomimaru, Yoshito ; Wada, Hiroshi ; Kawamoto, Koichi ; Kobayashi, Shogo ; Marubashi, Shigeru ; Tanemura, Masahiro ; Nagano, Hiroaki ; Mori, Masaki ; Doki, Yuichiro. / MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells. In: Biochemical and Biophysical Research Communications. 2011 ; Vol. 414, No. 4. pp. 675-680.
@article{ec1f4aee287440d8882000455b47098f,
title = "MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells",
abstract = "Background: Interferon-based (IFN-based) therapy is effective in the treatment of advanced hepatocellular carcinoma (HCC). However, the issue of resistance to this therapy remains to be solved. The aim of this study was to identify microRNAs (miRNAs) that govern the sensitivity to IFN-α in HCC cells. Methods: miRNA microarray analysis using IFN-α-resistant clones of PLC/PRF/5 (PLC-Rs) and their parental cells (PLC-P) was conducted. Changes in the anti-cancer effects of IFN-α were studied after gain-of-function and loss-of-function of the candidate miRNA. Results: miR-146a expression was significantly higher in PLC-Rs than in PLC-P. miR-146a decreased the sensitivity to IFN-α through the suppression of apoptosis. Further experiments showed that miR-146a-related resistance to IFN-α was mediated through SMAD4. Conclusions: The results indicated that miR-146a regulated the sensitivity of HCC cells to the cytotoxic effects of IFN-α through SMAD4, suggesting that this miRNA could be suitable for prediction of the clinical response and potential therapeutic target in HCC patients on IFN-based therapy.",
author = "Akira Tomokuni and Hidetoshi Eguchi and Yoshito Tomimaru and Hiroshi Wada and Koichi Kawamoto and Shogo Kobayashi and Shigeru Marubashi and Masahiro Tanemura and Hiroaki Nagano and Masaki Mori and Yuichiro Doki",
year = "2011",
month = "11",
day = "4",
doi = "10.1016/j.bbrc.2011.09.124",
language = "English",
volume = "414",
pages = "675--680",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - MiR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

AU - Tomokuni, Akira

AU - Eguchi, Hidetoshi

AU - Tomimaru, Yoshito

AU - Wada, Hiroshi

AU - Kawamoto, Koichi

AU - Kobayashi, Shogo

AU - Marubashi, Shigeru

AU - Tanemura, Masahiro

AU - Nagano, Hiroaki

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2011/11/4

Y1 - 2011/11/4

N2 - Background: Interferon-based (IFN-based) therapy is effective in the treatment of advanced hepatocellular carcinoma (HCC). However, the issue of resistance to this therapy remains to be solved. The aim of this study was to identify microRNAs (miRNAs) that govern the sensitivity to IFN-α in HCC cells. Methods: miRNA microarray analysis using IFN-α-resistant clones of PLC/PRF/5 (PLC-Rs) and their parental cells (PLC-P) was conducted. Changes in the anti-cancer effects of IFN-α were studied after gain-of-function and loss-of-function of the candidate miRNA. Results: miR-146a expression was significantly higher in PLC-Rs than in PLC-P. miR-146a decreased the sensitivity to IFN-α through the suppression of apoptosis. Further experiments showed that miR-146a-related resistance to IFN-α was mediated through SMAD4. Conclusions: The results indicated that miR-146a regulated the sensitivity of HCC cells to the cytotoxic effects of IFN-α through SMAD4, suggesting that this miRNA could be suitable for prediction of the clinical response and potential therapeutic target in HCC patients on IFN-based therapy.

AB - Background: Interferon-based (IFN-based) therapy is effective in the treatment of advanced hepatocellular carcinoma (HCC). However, the issue of resistance to this therapy remains to be solved. The aim of this study was to identify microRNAs (miRNAs) that govern the sensitivity to IFN-α in HCC cells. Methods: miRNA microarray analysis using IFN-α-resistant clones of PLC/PRF/5 (PLC-Rs) and their parental cells (PLC-P) was conducted. Changes in the anti-cancer effects of IFN-α were studied after gain-of-function and loss-of-function of the candidate miRNA. Results: miR-146a expression was significantly higher in PLC-Rs than in PLC-P. miR-146a decreased the sensitivity to IFN-α through the suppression of apoptosis. Further experiments showed that miR-146a-related resistance to IFN-α was mediated through SMAD4. Conclusions: The results indicated that miR-146a regulated the sensitivity of HCC cells to the cytotoxic effects of IFN-α through SMAD4, suggesting that this miRNA could be suitable for prediction of the clinical response and potential therapeutic target in HCC patients on IFN-based therapy.

UR - http://www.scopus.com/inward/record.url?scp=80555122819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555122819&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.09.124

DO - 10.1016/j.bbrc.2011.09.124

M3 - Article

C2 - 21982769

AN - SCOPUS:80555122819

VL - 414

SP - 675

EP - 680

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -